(Q43035513)

12 November 2017

Hepatitis C virus genotypes and the development of hepatocellular carcinoma (English)

1 reference

12 November 2017

1 reference

Dobrila Stankovic-Djordjevic

1

1 reference

12 November 2017

Nebojsa Djordjevic

2

1 reference

12 November 2017

Gordana Tasic

3

1 reference

12 November 2017

Marina Dinic

4

1 reference

12 November 2017

Aleksandar Karanikolic

5

1 reference

12 November 2017

Milica Pesic

6

1 reference

12 November 2017

1 February 2007

1 reference

Journal of Digestive Diseases

12 November 2017

1 reference

12 November 2017

8

1 reference

12 November 2017

1

1 reference

12 November 2017

42-47

1 reference

Genetic organization and diversity of the hepatitis C virus

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Variability of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C: the clinical spectrum of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus genotypes and development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Transcriptional repression of p53 promoter by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2007.00282.X

10.1111/J.1443-9573.2007.00282.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference